MetLife Investment Management LLC Has $4.58 Million Position in Option Care Health, Inc. (NASDAQ:OPCH)

MetLife Investment Management LLC raised its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 7.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 197,219 shares of the company's stock after buying an additional 14,311 shares during the period. MetLife Investment Management LLC owned about 0.12% of Option Care Health worth $4,575,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Cornerstone Investment Partners LLC raised its stake in Option Care Health by 3.6% during the 4th quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company's stock valued at $221,000 after purchasing an additional 333 shares during the period. UMB Bank n.a. raised its position in Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after buying an additional 346 shares during the period. Assetmark Inc. lifted its stake in Option Care Health by 2.0% in the 4th quarter. Assetmark Inc. now owns 24,976 shares of the company's stock worth $579,000 after acquiring an additional 487 shares in the last quarter. Pacer Advisors Inc. boosted its position in Option Care Health by 2.2% during the 4th quarter. Pacer Advisors Inc. now owns 25,483 shares of the company's stock worth $591,000 after acquiring an additional 537 shares during the period. Finally, Sheets Smith Wealth Management grew its stake in Option Care Health by 2.4% during the 4th quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company's stock valued at $553,000 after acquiring an additional 550 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.

Analysts Set New Price Targets

OPCH has been the subject of a number of research analyst reports. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their price target for the stock from $38.00 to $40.00 in a research report on Wednesday. JMP Securities reissued a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. Barrington Research reiterated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a report on Wednesday. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and lifted their price objective for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Finally, Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and upped their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $35.50.

Option Care Health Stock Up 5.3 %

Shares of NASDAQ OPCH traded up $1.62 during mid-day trading on Wednesday, reaching $32.31. 4,194,293 shares of the company traded hands, compared to its average volume of 1,809,966. The company's fifty day moving average is $33.34 and its two-hundred day moving average is $28.82. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The stock has a market cap of $5.31 billion, a PE ratio of 27.15, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.26 billion. During the same quarter last year, the company posted $0.26 earnings per share. The company's revenue for the quarter was up 16.3% compared to the same quarter last year. On average, analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Insider Buying and Selling at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.64% of the company's stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.